Fig. 2. Characterization of the biosynthetic intermediates in vivo. (A) HPLC analysis (UV at 254 nm) of KST relative metabolites by Micromonospora sp. strains. (I) Wild-type TP-A0468. (II) Mutant TG1708 (ΔkstB1). (III) Mutant TG1711 (ΔkstA15). (IV) Mutant TG1712 (ΔkstA16). (V) Mutant TG1713 (ΔkstA11). (VI) Mutant TG1714 (ΔkstA10). UV-Vis analysis (B) and chemical structures (C) of anthracycline metabolites produced by the mutants. 